Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2014 Update: New Research Report Available at Fast Market Research
Biocept, Inc. (Biocept) is a diagnostics service provider. The company provides molecular oncology laboratory services. Its services include prognostic CTC enumeration for various solid tumors, levels of sensitivity to detect CTCs, and molecular testing on CTCs. Biocept offers tests to various types of solid tumor cancers. The company's HER2 OncoCEE-BR test is used for the detection of circulating tumor cells (CTC) in the peripheral blood followed by genetic analysis of HER-2 and amplification by FISH. It provides services to other...
View full press release